Kematian pada Pasien COVID-19 Berdasarkan Komorbid dan Tingkat Keparahan
Downloads
Latar Belakang:. Penyakit Coronavirus 2019 merupakan penyakit sistem pernapasan yang baru saja muncul dan menjadi pandemi. Indonesia mengalami peningkatan jumlah kasus yang cukup drastis. Derajat keparahan yang dialami oleh pasien COVID-19 dapat dipengaruhi oleh berbagai hal seperti usia, penyakit komorbid, defisiensi vitamin D, dan obesitas. Penelitian ini bertujuan untuk mengetahui hubungan jumlah komorbid dan derajat keparahan terhadap kematian pada pasien COVID-19. Metode: Penelitian deskriptif analitik dengan rancangan cross sectional. Total sampel 1240 pasien COVID-19 RSPI Sulianti Saroso Tahun 2020 2021. Hasil: Komorbid terbanyak adalah hipertensi dan diabetes melitus, derajat keparahan kategori sedang dan outcome hidup. Hasil analisis ada hubungan antara jumlah komorbid dengan status kematian (OR=1,585). Ada hubungan diabetes melitus dengan status kematian pasien pada pasien COVID-19 (OR=1,927). Ada hubungan antara derajat keparahan dengan status kematian pada pasien COVID-19 (OR=12,699). Kesimpulan: Derajat keparahan, jumlah komorbid dan komorbid diabetes mellitus berhubungan merupakan faktor risiko kematian pada pasien COVID-19.
Downloads
Sena GR, Lima TPF, Vidal SA, Do Carmo Duarte MMB, Bezerra PGM, Fonseca Lima EJ, et al. Clinical characteristics and mortality profile of COVID-19 patients aged less than 20 years old in Pernambuco – Brazil. Am J Trop Med Hyg. 2021;104(4):1507–12.
Vermonte Philips TYW. Karakter dan Persebaran Covid-19 di Indonesia. CSIS Comment. 2020;(April):1–12.
JHU CCSE COVID-19. GitHub - CSSEGISandData/COVID-19: Novel Coronavirus (COVID-19) Cases, provided by JHU CSSE. Dataset COVID-19. 2021.
Rahel nadra. UPDATE 30 Desember 2021 Kasus Kematian akibat Covid-19 Bertambah 7.
Li X, Wang L, Yan S, Yang F, Xiang L, Zhu J, et al. Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China. Int J Infect Dis [Internet]. 2020;94:128–32. Available from: https://doi.org/10.1016/j.ijid. 2020.03.053
Putra IMAA. Hubungan Komorbiditas Terhadap Derajat Keparahan Admisi dan Outcome Pasien COVID-19 di Rumah Sakit Bethesda Yogyakarta. 2021;4(1):1–23.
Ramadan HKA, Mahmoud MA, Zakaria M, Aburahma, Elkhawaga AA, El-Mokhtar MA, et al. Predictors of severity and co-infection resistance profile in COVID-19 patients: First report from upper Egypt. Infect Drug Resist. 2020;13:3409–22.
Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. Lancet Reg Heal - West Pacific [Internet]. 2021;9:100108. Available from: https://doi.org/10.1016/j. lanwpc.2021.100108
Drew C, Adisasmita AC. Gejala dan komorbid yang mempengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020. Tarumanagara Med J. 2021;3(2):274–83.
Zhu Z, Cai T, Fan L, Lou K, Hua X, Huang Z, et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int J Infect Dis [Internet]. 2020;95:332–9. Available from: https://doi.org/10.1016/j.ijid. 2020.04.041
Badedi M, Darraj H, Alnami AQ, Makrami A, Mahfouz MS, Alhazmi K, et al. Epidemiological and clinical characteristics of deceased covid-19 patients. Int J Gen Med. 2021;14:3809–19.
Rozaliyani A, Savitri AI, Setianingrum F, Shelly TN, Ratnasari V, Kuswindarti R, et al. Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Med Indones. 2020;52(3):246–54.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA - J Am Med Assoc. 2020;323(11): 1061–9.
Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020 Jun;1–8.
Noor FM, Islam MM. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. J Community Health. 2020 Dec;45(6):1270–82.
Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, et al. Characteristics of Persons Who Died with COVID-19 - United States, February 12-May 18, 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul;69(28):923–9.
Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, et al. Clinical Characteristics of Hospitalized Individuals Dying With COVID-19 by Age Group in Italy. J Gerontol A Biol Sci Med Sci. 2020 Sep;75(9):1796–800.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet [Internet]. 2020;395(10223): 507–13. Available from: http://dx.doi.org/ 10.1016/S0140-6736(20)30211-7
Haryati H, Isa M, Assagaf A, Nurrasyidah I, Kusumawardhani E. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 in Ulin Regional Hospital Banjarmasin. J Respirasi. 2021;7(1):1.
Woolcott OO, Castilla-Bancayán JP. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico. Sci Rep [Internet]. 2021;11(1):1–10. Available from: https://doi.org/10.1038/s41598-021-88014-z
Mahamat-Saleh Y, Fiolet T, Rebeaud ME, Mulot M, Guihur A, El Fatouhi D, et al. Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: A systematic review and meta-analysis of observational studies. BMJ Open. 2021;11(10).
Bozkurt FT, Tercan M, Patmano G, Bingol Tanrıverdi T, Demir HA, Yurekli UF. Can Ferritin Levels Predict the Severity of Illness in Patients With COVID-19? Cureus. 2021;13(1):1–8.
Vasheghani M, Nasrin J, Parvaneh B, Mitra R, Majid M. The Association of 25 (OH) Vitamin D Levels and Severity and Outcome of COVID-19: A Cross-sectional Study | Research Square. Sci Rep [Internet]. 2021;25:1–20. Available from: https://www.researchsquare.com/article/rs-141034/v1
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA [Internet]. 2020;323(13):1239–42. Available from: https://doi.org/10.1001/ jama. 2020.2648
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
Betts BC, Young JW. Less Can Be More When Targeting Interleukin-6-Mediated Cytokine Release Syndrome in Coronavirus Disease 2019. Crit care Explor. 2020 Jun;2(6):e0138.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England). 2020 Mar;395(10229):1054–62.
Faustine I, Malik A, Andrajati R, Wanandi SI. Clinical Characteristics and Severity Profile of COVID-19 Patient with Hypertension in Palu, Central Sulawesi. Indones J Pharm. 2021;32(4):563–72.
Assal HH, Abdel-hamid HM, Magdy S, Salah M, Ali A, Elkaffas RH, et al. Predictors of severity and mortality in COVID-19 patients. Egypt J Bronchol [Internet]. 2022;16(1). Available from: https://doi.org/10.1186/s43168-022-00122-0